A Mass General Brigham study of malignant ascites has identified rare RORC-expressing dendritic cells that may promote immune ...

In a study published in Science Immunology, researchers used malignant ascites—fluid that accumulates in the abdomen of some ...

This study was co-led by Steven Blum, MD. Gary Reynolds, MD, PhD, Samuel Klempner, MD, and Alexandra-Chloé Villani, PhD, ...

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver ...

Splenomegaly resulting from portal hypertension can be caused by cirrhosis, hepatic venous outflow tract obstruction and extrahepatic portal vein obstruction. Both cirrhosis and hepatic venous outflow ...

THE problem of wasting ascites occurring in patients with cirrhosis of the liver is unsolved — both the pathogenesis of the ascites and its reliable cure. Recent observations have indicated the ...

Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic ...

Sequential approach. In patients with first-time ascites, a low-sodium diet of 40 to 80 mEq (1000-2000 mg) per day alone may lead to resolution of ascites. If not, diuretics should be added.

CARSON CITY, Nev., March 13, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of ...

ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...